CD73 对骨髓间充质干细胞增殖与衰老的影响

王琰 李琼 张三林 郭志坤*

doi:10.16098/j.issn.0529-1356.2017.06.006

PDF(768 KB)

解剖学报 ›› 2017, Vol. 48 ›› Issue (6) : 669-674. DOI: 10.16098/j.issn.0529-1356.2017.06.006

细胞和分子生物学

CD73 对骨髓间充质干细胞增殖与衰老的影响

王琰¹ 李琼¹ 张三林² 郭志坤^1*

作者信息 +

Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells

WANG Yan¹ LI Qiong¹ZHANG San-lin²GUO Zhi-kun ^1*

Author information +

文章历史 +

摘要

目的探讨 CD73 对骨髓间充质干细胞(BMSCs)增殖与衰老的影响。方法培养小鼠 BMSCs，构建慢病毒CD73 过表达载体和CD73 RNAi干扰载体，分别转染 BMSCs，实验分组：CD73 过表达组（OE组）、CD73 RNAi干扰组（RNAi组）和对照组（CON组）。衰老相关β-半乳糖苷酶(SA-β-Gal) 染色检测细胞的衰老情况； MTT 法检测细胞增殖能力变化；流式细胞术检测细胞周期变化；透射电子显微镜观测转染后细胞的超微结构；非损伤细胞功能分析仪检测细胞生长曲线。结果慢病毒转染 BMSCs后72 h和168 h，衰老细胞数量 RNAi 组> CON 组> OE 组（P<0.05）；转染后3～4d BMSCs的增殖能力为OE 组较 RNAi 组和 CON 组细胞增殖速度快（P<0.05）；转染后3d各组细胞周期的变化是：OE 组、RNAi 组和 CON 组的 G₁ 期细胞所占比例分别为25.9%、44.1%和 51.7%；S 期细胞所占比例分别为48.8%、30.9%和26.9%；G₂ 期细胞所占比例分别为25.2%、25.0%和21.4%；透射电子显微镜观察结果显示，OE 组细胞质内粗面内质网和核糖体增多；细胞生长曲线显示 OE 组高于 CON 组和 RNAi 组。结论 CD73促进 BMSCs增殖且抑制 BMSCs衰老。

Abstract

Objective To investigate the effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells (BMSCs). Methods The mouse BMSCs were cultured in vitro. We constructed lentivirus of CD73 overexpression and CD73 RNAi vectors and transfected into the BMSCs. The experimental groups were divided into three groups: CD73 overexpression group (OE group), CD73 RNAi interference group (RNAi group) and control group (CON group). Galactosidase (SA-β-Gal) staining was used to detect the cell senescence. Cell proliferation was measured by MTT assay. Cell cycle was detected by flow cytometry. Ultrastructures were observed by transmission electron microscopy (TEM). The cell growth curve was detected by non-injured cell function analyzer. Results The number of senescent cells in RNAi group was significantly higher than that in CON and OE groups (P<0.05) at 72 hours post-transfection. The proliferation of BMSCs in OE group was significantly higher than CON and RNAi groups at 72 and 96 hours post-transfection (P<0.05). The percentages of G₁phase cells in OE group, RNAi group and CON group were 25.9%, 44.1% and 51.7%, respectively, and that of S phase cells were 48.8%, 30.9% and 26.9%, respectively. The percentage of cells in G₂ phase were 25.2%, 25.0% and 21.4%, respectively. The result of transmission electron microscopy showed that the cell rough endoplasmic reticulum and the ribosomes were increased in the OE group. The cell growth curve showed that the cell proliferation ability in OE group was higher than that in CON group and RNAi group. Conclusion CD73 promotes BMSCs proliferation and inhibits BMSC senescence.

导出引用

王琰李琼张三林郭志坤. CD73 对骨髓间充质干细胞增殖与衰老的影响[J]. 解剖学报. 2017, 48(6): 669-674 https://doi.org/10.16098/j.issn.0529-1356.2017.06.006

WANG Yan LI Qiong ZHANG San-lin GUO Zhi-kun. Effect of CD73 on the proliferation and senescence of bone marrow mesenchymal stem cells[J]. Acta Anatomica Sinica. 2017, 48(6): 669-674 https://doi.org/10.16098/j.issn.0529-1356.2017.06.006

参考文献

［1］Rosi F, Carlucci F, Marinello E, et al.Ecto-5’-nucleotidase in B-cell chronic lymphocytic leukemia ［ J］.Biomed Pharmacother, 2002, 56(2):100-104.

［2］Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73［J］. Immunol Rev,1998,161:95-109.

［3］Beavis PA, Stagg J, Darcy PK, et al. CD73: a potent suppressor of antitumor immune responses［J］. Trends Immunol, 2012, 33(5): 231-237.

［4］Li Q, Qi LJ, Guo ZK, et al. CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro［J］. J Mol Histol, 2013, 44(4):411-422.

［5］Bavaresco L, Bernardi A, Braganhol E, et al. The role of ecto-5’-nucleotidase/CD73 in glioma cell line proliferation［J］. Mol Cell Bio Chem, 2008, 319(1-2):61-68.

［6］Allard B, Turcotte M, Stagg J. CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth. J Biomed Biotechnol, 2012, 85156.

［7］Park JS，Kim HY, Kim HW, et al．Increased caveolin-1，a cause for the declined adipogenic potential of senescent human mesenehymal stem cells［J］．Mech Ageing，2005, 126(5)：551-559．

［8］Andrade CM, Lopez PL, Noronha BT, et al. Ecto-5’-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line［J］. Cell Tissue Res, 2011, 344(2):279-286.

［9］Gao ZhW, Wang HP, Lin F, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity［J］. BMC Cancer, 2017, 17:135-136.［10］Zhi X, Wang Y, Yu J, et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer［J］. IUBMB Life, 2012，64(11):911-920.

［11］Bynoe MS, Viret C, Yan A, et al. Adenosine receptor signaling: a key to opening the blood-brain door［J］. Fluids Barriers CNS, 2015, 20(12):1-12.

［12］Colgan SP, Eltzschig HK, Eckle T, et al. Physiological roles for ecto-5’-nucleotidase (CD73)［J］. Purinergic Signal, 2006,2(2):351-360.

［13] Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation［J］. N Engl J Med, 2012, 367(24):2322-2333.

［14］Ohta A. A metabolic immune checkpoint: adenosine in tumor microenvironment［J］. Front Immunol, 2016,109(7):1-11.

［15］B?nner F, Borg N, Jacoby C, et al. Ecto-5’-nucleotidase on immune cells protects from adverse cardiac remodeling［J］. Circ Res, 2013, 113(3):301-312.